BEUDAMED
    FDA Adverse Event Injury Summary report: Y

    NERIVIO

    MDR report key: 15391410 · Received September 9, 2022

    Report

    Report Number
    3015379717-2022-00003
    Event Type
    Injury
    Date Received
    September 9, 2022
    Date of Event
    August 2, 2022
    Report Date
    August 29, 2022
    Manufacturer
    THERANICA BIO-ELECTRONICS LTD.
    Product Code
    QGT
    UDI-DI
    07290017578026
    PMA / PMN Number
    DEN180059
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    003

    Narratives

    Additional Manufacturer Narrative · 0

    (B)(4). ACCORDING TO THE USER, SHE PERFORMED 5 TREATMENTS WITH THE DEVICE, INCLUDING THE TREATMENT OF WHICH THE EVENT OCCURS. AS THE TREATMENT ACTIVATED BY AN APP, THE LOG FILE OF EACH TREATMENT IS RECORDED IN AN UNIDENTIFIED MANNER WITHIN THE MANUFACTURER DATA SERVERS. THE MANUFACTURER INVESTIGATED THE LOG FILES OF THE 5 TREATMENTS THAT WERE PERFORMED WITH THIS SPECIFIC DEVICE. THE RECORDS DEMONSTRATED THAT THERE WERE NO PROBLEMS OR MALFUNCTIONS OF THE DEVICE THROUGHOUT THE TREATMENTS. THE TREATMENTS PARAMETERS WERE SIMILAR IN THEIR VALUES, AS CAN BE SEEN IN THE FOLLOWING TABL. THE EVENT WAS PERFORMED UNDER THE LOWEST ELECTRICAL CURRENT IN RELATED TO THE REST OF THE TREATMENTS (INTENSITY OF 20% WITH OUTPUT OF 175). USING INTENSITY LEVEL OF 20% IS LOWER THAN THE AVERAGE INTENSITY LEVEL THAT IS USED IN THE MARKET, WHICH IS APPROX. 31%. THE USER ALSO STATED THAT PREVIOUS TREATMENTS WERE HELPFUL IN THE TREATMENT OF HER MIGRAINES TREATMENT, DATE, TREATMENT TIME, AVERAGE INTENSITY, ELECTRICAL OUTPUT, (B)(6). IN GENERAL, NERIVIO COMPLIES WITH THE FOLLOWING STANDARDS: IEC-60601-1 GENERAL REQUIREMENTS FOR SAFETY, MEDICAL ELECTRICAL EQUIPMENT IEC 60601-1-2 GENERAL REQUIREMENTS FOR BASIC SAFETY AND ESSENTIAL PERFORMANCE - COLLATERAL STANDARD: ELECTROMAGNETIC DISTURBANCES IEC 60601-1-11 MEDICAL ELECTRICAL EQUIPMENT. GENERAL REQUIREMENTS FOR BASIC SAFETY AND ESSENTIAL PERFORMANCE - COLLATERAL STANDARD: REQUIREMENTS FOR MEDICAL ELECTRICAL EQUIPMENT AND MEDICAL ELECTRICAL SYSTEMS USED IN THE HOME HEALTHCARE ENVIRONMENT. IEC 60601-2-10 MEDICAL ELECTRICAL EQUIPMENT. PARTICULAR REQUIREMENTS FOR THE BASIC SAFETY AND ESSENTIAL PERFORMANCE OF NERVE AND MUSCLE STIMULATORS. BASED ON THE ABOVE INFORMATION, WE CONCLUDE THAT THE DEVICE DID NOT MALFUNCTION. TO THE BEST OF OUR KNOWLEDGE, SUCH EVENT OF BALANCE AND TINITUS WERE NOT REPORTED BEFORE WHILE USING NERIVIO. IT SEEMS THAT THE EVENT IS NOT RELATED TO THE DEVICE OR PROCEDURE MALFUNCTION, BUT THAT POSSIBILITY CANNOT BE CONCLUSIVELY RULED OUT. FURTHER, IT WAS NOT CLEAR THAT THERE WAS A POTENTIAL FOR PERMANENT IMPAIRMENT OR DAMAGE IN THIS INSTANCE, BUT THE USER SOUGHT OUT MEDICAL CARE. AS SUCH, WE ARE REPORTING THIS EVENT OUT AN ABUNDANCE OF CAUTION AND TO FNSURE FULL COMPLIANCE WITH OUR REPORTING OBLIGATIONS.

    Description of Event or Problem · 0

    THE USER LEFT A REVIEW ON NERIVIO WEBSITE. THE REVIEW WAS "INITIALLY, NERIVIO HELPED. AFTER MY 5TH USE, I DEVELOPED A LOUD RINGING IN MY EARS, INTENSE VERTIGO AND NAUSEA, AND DISORIENTATION. IT HAS TAKEN WEEKS TO GET MY BALANCE BACK. I WOULD NOT RECOMMEND IT TO AN Y ONE NOR WILL I EVER USE IT AGAIN." NERIVIO CUSTOMER SUPPORT TRY TO CONTACT THE USER SEVERAL TIMES AND WAS ABLE TO REACH THE USER ON (B)(6) 2022, AND ASKED FOR ADDITIONAL INFORMATION REGARDING THE EVENT. THE USER GAVE THE FOLLOWING INFORMATION: THIS EVENT TOOK PLACE ON (B)(6) 2022, IN THE EVENING. THE USER WAS ON VACATION IN THE (B)(6) WHEN THE FIRST SIGNS OF A MIGRAINE CAME ON. WHEN THE FIRST SIGNS OF A MIGRAINE CAME ON, THE USER WAS ABLE TO START TREATING WITHIN THE HOUR OF ONSET. THE USER SAYS THAT SHE HAS BEEN TO THIS REGION MANY TIMES IN THE LAST 35 YEARS, BUT DOES NOT LIVE AT A HIGHER ELEVATION NORMALLY. THE USER STATES THAT AFTER THE TREATMENT (45 MINUTES AT AN INTENSITY OF 20%) SHE GOT A WEIRD FEELING IN HER HEAD AND A LOUD NOISE LIKE A RINGING. ALMOST LIKE THAT OF A BLARING FIRE ENGINE SIREN. USER EXPERIENCED TERRIBLE VERTIGO AND NAUSEA. THE USER EXPERIENCED A LACK OF BALANCE AND HAD DIFFICULTY SAYING WORDS. SHE COULD NOT STAND UP OR WALK. SHE COULD NOT SLEEP AT ALL THAT NIGHT BECAUSE SHE HAD A CONSTANT SPINNING FEELING AND RINGING IN HER EARS. THE USER STAYED IN BED MOST OF THE NEXT DAY AND MOST OF THE VERTIGO DISAPPEARED WITHIN THAT NEXT DAY. WHEN THE USER RETURNED TO HER HOME AFTER THIS VACATION, SHE WENT TO THE CHIROPRACTOR MULTIPLE TIMES AS HER BALANCE IS STILL NOT GOOD EVEN THOUGH THE VERTIGO SYMPTOMS SEEMED TO HAVE SUBSIDED. SHE HAS BEEN TO A MASSAGE THERAPIST AND A SACRAL THERAPIST ALONG WITH A BALANCE SPECIALIST TO HELP HER WITH THIS. THE USER DENIES ANY HISTORY OF SYNCOPAL EPISODES OR VERTIGO. USER HAS NO DIAGNOSIS OTHER THAN HAVING EPISODIC MIGRAINES PERIODICALLY. THE USER DENIES ANY MEDICATIONS, STATED THAT SHE DOES NOT EVEN TAKE AN ADVIL. THE USER DOES NOT WISH TO SHARE THIS REPORT AGAIN WITH ANOTHER PERSON AS THIS HAS ALREADY TAKEN ENOUGH TIME AND SHE IS A BUSY PERSON. THE USER STATES THAT "SHE KNOWS THIS WAS CAUSED BY NERIVO AND HAS MADE SURE TO TELL HER CHIROPRACTOR AND OTHERS AS WELL. SHE WILL NOT BE USING THE DEVICE EVER AGAIN." FOLLOWING THIS PHONE CALL, THERANICA RESPECTED THE USER REQUEST NOT TO CONTACT HIM AGAIN.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1307487 NERIVIO NERIVIO QGT THERANICA BIO-ELECTRONICS LTD. FGD000075 2142 07290017578026

    Patients

    Seq Age Sex Outcome Treatment
    1 66 YR Female Other